3 Reasons Clinics Are Switching to STAAR GPS™
By STAAR LABS | May 2025
The weight loss industry is evolving.
Patients want results. Providers want safe, compliant tools.
STAAR GPS™ delivers both.
Here’s why leading clinics are abandoning GLP-1 monotherapy and adopting the STAAR GPS Protocol™ — a smarter, multi-pathway approach that addresses today’s clinical realities.
✅ Reason 1: GLP-1s Alone Just Don’t Cut It
Yes, semaglutide, dulaglutide, and liraglutide have transformed weight loss care. But they’re also incomplete on their own:
-
Amylin signaling (satiety, glucose regulation) is ignored
-
Muscle loss risk increases with rapid weight loss
-
Patients plateau early, often within 8–12 weeks
-
GIP support is nonexistent — yet crucial to long-term metabolic success
STAAR GPS™ solves this.
By combining a GLP-1 with pramlintide + SLM+, GPS protocols re-activate stalled weight loss pathways and amplify results with less rebound risk.
🧠 Reminder: Liraglutide and Dulaglutide = Suboptimal Alone
Whether you’re prescribing a branded GLP-1 or a compliant compounded option, clinical outcomes are consistently enhanced when:
-
Pramlintide (synthetic amylin) is added to regulate post-meal glucose and prolong satiety
-
SLM+ is layered in to boost insulin sensitivity, mimic GIP activity, and protect lean mass
No matter the GLP-1 — commercial, compounded, or manufactured — you can apply the GPS Protocol™ to improve results.
✅ Reason 2: It’s Legally Safe and Medically Sound
The STAAR GPS Protocol™ was built for today’s regulatory environment:
-
GLP-1 + pramlintide are prescribed by licensed medical professionals
-
SLM+ is a GMP-certified nutraceutical formulated for metabolic support
-
No use of banned or restricted GLP-1s
-
Fully compliant with DSHEA, FDA, and FTC guidance
Providers retain prescribing control.
Patients get structured care.
Everyone stays protected.
✅ Reason 3: It’s Built for Real-World Clinics
GLP-1 shortages, semaglutide bans, and high brand-name prices have created chaos for clinics.
STAAR GPS™ gives you a scalable, dependable protocol that works whether you’re:
-
Running a boutique weight loss clinic
-
Transitioning from compounded semaglutide and tirzepatide
-
Working with underserved or cost-conscious patients
The model works with your existing infrastructure — not against it.
📦 Protocol Options for Every Patient
-
GPS-L™: Liraglutide + Pramlintide + SLM+
-
GPS-D™: Dulaglutide + Pramlintide + SLM+
-
Custom GLP-1 + GPS Model: Patients already on semaglutide, tirzepatide, or compounded options can add SLM+ + Pramlintide to convert to a full GPS-compatible protocol.
📍 Note: STAAR LABS does not provide pramlintide or GLP-1 medications. These must be prescribed and fulfilled by your licensed provider or pharmacy.
💬 Clinic Testimonial
“We were frustrated with semaglutide shortages and didn’t know where to turn. With GPS-L and GPS-D, we now offer safer, cost-effective options that keep our patients progressing.”
— L. Caldwell, NP | Integrative Wellness Clinic
⚠️ Disclaimers
Medical Disclaimer: This content is provided for educational purposes only and is not intended as medical advice. The STAAR GPS Protocol™ must be prescribed and managed by a licensed healthcare provider. Individual results may vary.
Supplement Disclaimer: SLM+ by STAAR LABS is a dietary supplement. These statements have not been evaluated by the Food and Drug Administration (FDA). This product is not intended to diagnose, treat, cure, or prevent any disease.
Compliance Note: STAAR LABS does not sell or distribute prescription medications. All pharmaceutical components of the GPS Protocol™ are provided through licensed healthcare providers and regulated compounding pharmacies.
Research Disclosure: STAAR LABS collaborates with clinics and licensed professionals to develop innovative metabolic health strategies that integrate pharmaceutical and nutraceutical interventions.
